CANCER CACHEXIA

This early-stage trial tests a new drug called GB18, designed to treat cancer cachexia—a condition where cancer patients lose weight and muscle. The study involves 36 healthy adults to check the drug's safety and how the body processes it. Participants receive a single injection …

This study tests whether a drug called NPX-5 (psilocybin) combined with talk therapy can reduce severe anxiety in people who have been diagnosed with cancer. About 87 adults aged 18 to 80 will receive one of three doses (25 mg, 10 mg, or 1 mg) during an 8-hour therapy session. Th…

This study looks at two different exercise programs—flexi band resistance training and whole-body electrical muscle stimulation—for people with cancer. The goal is to see which one better improves muscle strength, body composition, and quality of life. About 100 participants will…

This study tests an experimental drug called NGM120 in 136 people with colorectal cancer who are experiencing cancer-related weight loss (cachexia). The goal is to see if the drug helps patients maintain or gain weight over 12 weeks compared to a placebo. The study is currently r…

This study looks at why some colorectal cancer patients lose muscle mass (cachexia), which is linked to higher death rates. Researchers will take small muscle samples and use scans to compare muscle structure in 60 people: those with cachexia, those without, and healthy volunteer…

This study aims to test a new AI tool designed to spot severe, muscle-wasting weight loss (cachexia) early in people with pancreatic cancer. It will also check how practical and acceptable diet and exercise plans are for managing this condition. The research will involve about 12…